Neutralizing the Neutralizers in AAV Gene Therapy

dc.contributor.authorHerzog, Roland W.
dc.contributor.authorBiswas, Moanaro
dc.contributor.departmentPediatrics, School of Medicineen_US
dc.date.accessioned2023-02-23T15:47:45Z
dc.date.available2023-02-23T15:47:45Z
dc.date.issued2020-08-05
dc.eprint.versionFinal published versionen_US
dc.identifier.citationHerzog RW, Biswas M. Neutralizing the Neutralizers in AAV Gene Therapy. Mol Ther. 2020;28(8):1741-1742. doi:10.1016/j.ymthe.2020.07.015en_US
dc.identifier.urihttps://hdl.handle.net/1805/31418
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/j.ymthe.2020.07.015en_US
dc.relation.journalMolecular Therapyen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectNeutralizing antibodiesen_US
dc.subjectDependovirusen_US
dc.subjectEndopeptidasesen_US
dc.subjectGenetic therapyen_US
dc.subjectImmunoglobulin Gen_US
dc.titleNeutralizing the Neutralizers in AAV Gene Therapyen_US
dc.typeArticleen_US
ul.alternative.fulltexthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403453/en_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
main.pdf
Size:
127.98 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: